Janaki M. Vinnakota

Freiburg, BW, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications

Spatial Transcriptomics reveals a T cell-mediated microglial activation axis of neurodegeneration following immune checkpoint inhibition.

Spatial Transcriptomics reveals a T cell-mediated microglial activation axis of neurodegeneration following immune checkpoint inhibition.

Journal: bioRxiv : the preprint server for biology
Published: June 22, 2026

A transcriptomic microglia taxonomy across mouse and human pathologies.

A transcriptomic microglia taxonomy across mouse and human pathologies.

Journal: Nature immunology
Published: November 28, 2025

Biology-driven therapies of CAR T immune effector cell-associated neurotoxicity syndrome.

Biology-driven therapies of CAR T immune effector cell-associated neurotoxicity syndrome.

Journal: Immunotherapy
Published: May 29, 2025

Protocol for performing and analyzing a live-cell imaging-based microglia phagocytosis assay using AI on the Olympus ScanR system.

Protocol for performing and analyzing a live-cell imaging-based microglia phagocytosis assay using AI on the Olympus ScanR system.

Journal: STAR protocols
Published: January 10, 2025

Extracorporeal Photopheresis: From Animal Models to Clinical Practice.

Extracorporeal Photopheresis: From Animal Models to Clinical Practice.

Journal: Transplantation direct
Published: December 20, 2024

Gut microbiota-derived TMAVA is a modulator of acute CNS-GVHD.

Gut microbiota-derived TMAVA is a modulator of acute CNS-GVHD.

Journal: The Journal of experimental medicine
Published: November 19, 2024

AIstain: Enhancing microglial phagocytosis analysis through deep learning.

AIstain: Enhancing microglial phagocytosis analysis through deep learning.

Journal: Cell reports methods
Published: October 22, 2024

AhR activation mitigates graft-versus-host disease of the central nervous system by reducing microglial NF-κB signaling.

AhR activation mitigates graft-versus-host disease of the central nervous system by reducing microglial NF-κB signaling.

Journal: Blood advances
Published: October 04, 2024

Regulatory T cell therapy for Graft-versus-Host Disease.

Regulatory T cell therapy for Graft-versus-Host Disease.

Journal: Bone marrow transplantation
Published: September 01, 2024

Anti-PD-1 cancer immunotherapy induces central nervous system immune-related adverse events by microglia activation.

Anti-PD-1 cancer immunotherapy induces central nervous system immune-related adverse events by microglia activation.

Journal: Science translational medicine
Published: June 12, 2024

Oncogenic Calreticulin Induces Immune Escape by Stimulating TGFβ Expression and Regulatory T-cell Expansion in the Bone Marrow Microenvironment.

Oncogenic Calreticulin Induces Immune Escape by Stimulating TGFβ Expression and Regulatory T-cell Expansion in the Bone Marrow Microenvironment.

Journal: Cancer research
Published: November 10, 2023

CSF1R inhibition promotes neuroinflammation and behavioral deficits during graft-versus-host disease in mice.

CSF1R inhibition promotes neuroinflammation and behavioral deficits during graft-versus-host disease in mice.

Journal: Blood
Published: August 01, 2023
Showing 1-12 of 22

Last Updated: 09/26/2026